Animal Sedative Market Size To Reach $227.0 Million By 2033

Animal Sedative Market Growth & Trends

The global Animal Sedative market size is expected to reach USD 227.0 Million by 2033, registering a CAGR of 6.04% from 2025 to 2033, according to a new report by Grand View Research, Inc. The primary drivers of market growth include the rising prevalence of chronic diseases in animals, rising pet ownership, increasing number of surgical procedures, and increasing animal health expenditure. Furthermore, the rise in pet humanization has led to an expansion of veterinary services, including behavioral therapy and specialized treatments. Vets are more frequently prescribing sedatives for pets undergoing surgeries, dental procedures, and other medical interventions, contributing to market growth. In addition, pet insurance acceptability is increasing as a result of a number of causes, including pet humanization, expanding pet population, increased initiatives by major corporations, and rising veterinary care costs. The AVMA reports that pet owners are increasingly using pet insurance to help them pay for their pets' medical expenses.

There is a growing awareness about the importance of controlling the pet population to reduce the number of stray animals. This has led to an increase in the number of spaying procedures. Spaying, being a surgical procedure, requires anesthesia or sedatives to ensure the animal remains pain-free and immobile during the operation. As more pet owners bring their pets to veterinarians for spaying, the overall number of veterinary visits increases, driving the demand for veterinary pharmaceuticals, including sedatives. The use of sedatives in spaying dogs is an essential part of the veterinary procedure, ensuring the safety and comfort of the animal. For instance, according to an article published by Pangolia Pte. Ltd., in April 2024, in the United States, 85% of dogs have been neutered or spayed.

Moreover, global pet population growth is fueling the market growth. Over the past few years, the number of pets has increased drastically as more and more households have decided to adopt a pet to improve their quality of life. According to estimates from the Global Animal Health Association, the number of dogs in the United States alone is over 85 million. This association estimates that almost half a billion dogs and cats are owned by families in the United States, Europe, and China. In contrast, the country's dog and cat populations expanded dramatically between 2020 and 2022, as per the Canadian Animal Health Institute (CAHI). According to CAHI forecasts for 2022, the annual medicalization rate for dogs remained stable at 86%, while the medicalization rate for cats climbed by over 3%. This indicated that more pet cats visited veterinarians between 2020 and 2022. Therefore, the necessity for treating a variety of illnesses, such as arthritis in dogs and cats, rises along with the proportion of people who own pets.

 Request a free sample copy or view report summary: Animal Sedative Market Report

Animal Sedative Market Report Highlights

• Euthanasia represented the largest segment with a revenue share of 37.78% in 2024, driven by the rising need for humane end-of-life solutions for companion and livestock animals. Increasing awareness among pet owners regarding ethical euthanasia practices, coupled with stringent animal welfare regulations, has significantly boosted demand

• The dogs segment led the animal sedatives market with the largest share of about 40.0% in 2024, driven by their high population, widespread ownership, and frequent need for sedation in veterinary care. Sedatives are commonly used in dogs for diagnostic imaging, surgical procedures, grooming, and behavioral management.

• The parenteral segment held the largest share of the animal sedative market in 2024, primarily due to its rapid onset, precise dosing, and reliable efficacy across various animal species. Injectable sedatives are widely preferred by veterinarians for surgical procedures, diagnostic interventions, and emergency treatments in pets, livestock, and exotic animals.

• Alpha-2 Adrenergic Receptor Agonists has emerged as both the largest and fastest-growing segment in the market, driven by their multifaceted pharmacological benefits. In July 2022, Dechra and Vetcare Oy launched Zenalpha, an alpha2 adrenergic agonist combining medetomidine and vatinoxan, offering effective sedation and analgesia while reducing cardiovascular side effects during exams and minor procedures.

• Veterinary hospitals and clinics represent the largest segment in the animal sedatives market, owing to their critical role in administering sedatives for surgical procedures, diagnostics, and routine animal care.

• The North America animal sedatives market held the largest revenue share of 37.70% in 2024, led by key players such as Zoetis, Dechra, and Virbac. Rising pet ownership, advanced veterinary procedures, and increasing awareness of animal welfare drive growth

Animal Sedative Market Segmentation

Grand View Research has segmented the global animal sedative market report based on application, animal, route of administration, drug class, end use, and region:

Animal Sedative Application Outlook (Revenue, USD Million, 2021 - 2033)

• Surgical

• Diagnostic

• Euthanasia

• Others

Animal Sedative Animal Outlook (Revenue, USD Million, 2021 - 2033)

• Dogs

• Cats

• Horses

• Others

Animal Sedative Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

• Parenteral

• Oral

Animal Sedative Drug Class Outlook (Revenue, USD Million, 2021 - 2033)

• Phenothiazines

• Benzodiazepines

• Alpha-2 Adrenergic Receptor Agonists

• Butyrophenones

• Others

Animal Sedative End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Veterinary Hospitals & Clinics

• Specialty Centers

• Others

Animal Sedative Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • India

  • China

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Qatar

  • Oman

List of Key Players in Animal Sedative Market

• Zoetis Services, LLC

• Virbac

• Ouro Fino Saude Animal Group

• Dechra

• Merck & Co., Inc.

• Bimeda Inc.

• vetcare. fi.

• Chanelle Pharma (Exponent)

• Randlab Australia Pty Ltd

• Troy Laboratories Pty Ltd